Seven cases of cystic fibrosis complicated by chronic salt depletion and failure to thrive were studied. After replacement of the salt deficit, the metabolic abnormalities resolved, and weight gain was rapid. This should be considered as a differential diagnosis in children who have been diagnosed as having cystic fibrosis, but who fail to thrive despite standard treatment.
electrolyte concentrations (hyponatraemia, hypokalaemia, and hypochloraemia) is uncommon in infancy. In the United Kingdom the more common causes included pyloric stenosis, gastric drainage without electrolyte replacement, and-less common-chloride losing nephropathy, the use of thiazide diuretics, and Bartter's syndrome. Acute salt loss in cystic fibrosis is well known, but the gradual development of abnormally low serum electrolyte concentrations, metabolic alkalosis, and failure to thrive without severe dehydration is less widely recognised. Though most cases have been reported from North America, the syndrome has also been described in the United Kingdom. 1 We describe seven cases who presented to -NaCI, sodium chloride; KCI, potassium chloride. Although the biochemical hallmark of both Bartter's and pseudo-Bartter's syndrome is abnormally low plasma electrolyte concentrations, there are important differences between the two diseases. In Bartter's syndrome, the sweat electrolyte profile is normal (MJ Dillon, personal communication) and the renal handling of electrolytes is defective. In cystic fibrosis, sweat electrolyte loss is increased, and intensive reabsorption occurs in the renal tubules. The effect of this electrolyte loss is contraction of the extracellular space and activation of the reninangiotensin system.2 In some of our patients plasma renin activity was high but plasma aldosterone concentrations were normal, as low plasma potassium concentrations may suppress the release of aldosterone. All our cases presented during the warmer months when it is likely that they had increased electrolyte losses in sweat. It is also important to note that low solute formula milks have only half the salt content of older formula milks, and the apparently increasing number of children with pseudo-Bartter's syndrome and cystic fibrosis may be partly a consequence of the change to low solute milks in the mid 1970s.
It is difficult to lay down rigid guidelines about the duration of treatment with electrolyte supplements that is required. Sodium or potassium supplements, or both, were given as needed to maintain a normal plasma electrolyte profile. They were continued until the growth curve had returned to normal and stopped when it was clear that plasma electrolyte concentrations remained satisfactory without the need for supplements.
In conclusion, pseudo-Bartter's syndrome should be considered in children with cystic fibrosis who are failing to thrive despite conventional treatment. In children presenting with metabolic alkalosis and abnormally low serum electrolytes, cystic fibrosis should be included in the differential diagnosis.
